Non-alcoholic Steatohepatitis Flashcards
Define NASH
inflammation of the liver, accompanied by hepatocyte steatosis, that cannot be attributed to any other cause (i.e. not alcoholic, not autoimmune and not viral). It is a subset of non-alcoholic fatty liver disease (NAFLD)
What are the stages of NASH?
- Steatosis –fat deposition in the liver
- Steatohepatitis
- Fibrosis
- Cirrhosis
What are the causes/risk factors of NASH?
- NASH most commonly occurs due to insulin resistance as part of the metabolic syndrome.
- Age
- Obesity
- T2DM and Insulin Resistance
- Dyslipidaemia
- Hypertension
- Metabolic Syndrome, 3 of: Obesity, Hypertension, Diabetes/ IR, Hypertriglyceridaemia and dyslipidaemia
What are the symptoms of NASH?
- Non-alcoholic
- History of components of the metabolic syndrome
- Usually asymptomatic, even at an advanced stage of the disease; incidental findings.
- Non-specific symptoms: Fever, fatigue malaise, RUQ pain and jaundice.
- May present with upper GI bleeds due to oesophageal varices secondary to portal hypertension
What are the signs of NASH?
• Early on, there will be no signs on examination.
• Later, the patient will develop the classical stigmata of chronic liver disease:
- Asterixis, Ascites, Ankle Oedema, Atrophy of testicles
- Bruises and Petechiae
- Clubbing, Colour change in the nails (Leukonychia), Caput Medusae
- Dupuyten’s Contractures
- Erythema (Palmar), Encephalopathy
- Foetor hepaticus
- Gynaecomastia and hair loss
- Hepatomegaly
- Increase size of parotids, Itching/pruritus due to BR deposition in the skin.
- Jaundice; Spider Naevi and Striae
What investigations are carried out for NASH?
• FBC - macrocytic (High MCV) Anaemia, Leucocytosis and Thrombocytopaenia.
• LFTs - elevated ALT and AST, AST: ALT Ratio < 1, raised GGT –very sensitive, high BR, low Albumin
• Lipid Panel - elevated total cholesterol, LDL, triglyceride, and low HDL.
• Fasting Insulin - elevated (indicates IR).
• Clotting Screen - PT and INR: Prolonged
• Serum Ammonia - elevated ammonia level does not correlate with severity of hepatic encephalopathy alone. Therefore, its routine use in diagnosis of hepatic encephalopathy is not always necessary.
• Ascitic Fluid Tap - if ascites, to screen for infection –SBP: Subacute Bacterial Peritonitis.
• Liver USS - may show hepatomegaly, fatty liver, liver cirrhosis. May show masses and malignancies.
• OGD - shows upper GI bleeding and oesophageal varices.
• Liver Biopsy - percutaneous or transjugular (in the presence of coagulopathy) may be helpful to distinguish from other causes of hepatitis. Biopsy shows: steatosis, inflammation-neutrophil infiltrate, ballooning hepatocytes, Mallory hyaline bodies, pericellular fibrosis.
• EEG - for slow-wave activity indicative of encephalopathy.
• CT/ MRI - may show hepatomegaly, splenomegaly, ascites, and portal vein engorgement.
• Liver Elastography -
measures liver stiffness and indicates extent of damage and presence of cirrhosis.
• Other Investigations (to rule out other causes of liver disease):
- Viral serology –Viral Hepatitis.
- Caeruloplasmin and urinary copper –Wilson’s disease
- Fe, Ferritin and transferrin saturation –Haemochromatosis
- α1-Antitrypsin –α1-Antitrypsin Deficiency
- Antimitochondrial antibodies –PBC.
- Autoantibodies for AIH.
What is the management for NASH?
Conservative: • Weight loss • diabetes control • caloric restriction diet • physical activity
Medical:
• Orlistat
• Insulin sensitisers and drugs for T2DM
• Statins for dyslipidaemia
Surgical:
• Liver transplantation for end-stage liver disease. NASH is projected to be the primary indication for liver transplantation worldwide, superseding Hepatitis C.
• Transjugular Intrahepatic Portosystemic Shunt
• Bariatric surgery for insulin resistance and obesity
Monitoring:
• If cirrhosis is present, then a liver USS twice/ year to exclude HCC.
• Monitor for complications including cardiovascular disease risks and diabetic microvascular complications
What are the complications of NASH?
- Decompensated liver disease: encephalopathy, jaundice and ascites
- Hepatorenal syndrome: Renal failure secondary to liver disease
- Cirrhosis
- Liver failure
- HCC
- Increases the risk of DM, MI, stroke